News
Lucas Camillo and Bo Wang release CpGPT, a foundation model for DNA methylation
Read more
Shift Bioscience raises $16M to advance cell simulation AI platform
Read more
Guardian article on rejuvenation race mentions Shift Bioscience
Read more
Daniel Ives features in Cambridge University's Enterprising Minds
Read more
Daniel interviewed by Eleanor Sheekey
Read more
Nature Biotechnology features Shift Bioscience
Read more
Shift Bioscience at the Investing in the Age of Longevity conference in London
Read more
FT features Shift Bioscience in The Weekend Essay
Read more
Daniel Ives presents to the Foresight Biotech & Health extension
Read more
CEO Daniel Ives discusses Shift Bioscience on BioInnovation Spotlight
Read more